Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao

References

• Sedgh G, Henshaw S, Singh S, Induced abortion: Estimated rates and trends worldwide. Lancet 2007;370: 1338–45.
   PubMed Web of Science ®Google Scholar
• Singh S. Hospital admissions resulting from unsafe abortions: Estimates from 13 developing countries. Lancet 2006;368:1887–92.
   PubMed Web of Science ®Google Scholar
• Bartz D, Goldberg AB. Medication abortion. Clin Obstet Gynecol 2009;52:140–50.
   PubMed Web of Science ®Google Scholar
• Cameron S, Glasier A, Dewart H, Women's experiences of the final stage of early medical abortion at home: Results of a pilot survey. J Fam Plann Reprod Health Care 2010;36:213–6.
   PubMed Web of Science ®Google Scholar
• Akin A, Dabash R, Dilbaz B, Increasing women's choices in medical abortion: A study of misoprostol 400 μg swallowed immediately or held sublingually following 200 mg mifepristone. Eur J Contracept Reprod Health Care 2009;3:169–75.
   Web of Science ®Google Scholar
• Boersma AA, Meyboom-de Jong B. Good results for early medical termination of pregnancy in a general practice in Curaçao. Ned Tijdschr Geneeskd 2008;152:504–8.
   PubMedGoogle Scholar
• Gouk EV, Lincoln K, Khair A, Medical termination of pregnancy at 63 to 83 days gestation. Br J Obstet Gynaecol 1999;106:535–9.
   PubMedGoogle Scholar
• Hamoda H, Ashok PW, Flett GMM, Templeton A. Medical abortion at 9–13 weeks' gestation: A review of 1076 consecutive cases. Contraception 2005;71:327–32.
   PubMed Web of Science ®Google Scholar
• Kopp Kallner H, Fiala C, Stephansson O, Home self administration of vaginal misoprostol for medical abortion at 50–63 days compared with gestation of below 50 days. Hum Reprod 2010;25:1153–7.
   PubMed Web of Science ®Google Scholar
• Chuni N, Chandrashekhar TS. Early pregnancy termination with a simplified mifepristone: Medical abortion outpatient regimen. Kathmandu Univ Med J 2009;7: 209–12.
   PubMedGoogle Scholar
• Tang O, Schweer H, Seyberth H, Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332–6.
   PubMed Web of Science ®Google Scholar
• Winikoff B, Dzuba IG, Creinin MD, Two distinct oral routes of misoprostol in mifepristone medical abortion: A randomized controlled trial. Obstet Gynecol 2008;112:1303–10.
   PubMed Web of Science ®Google Scholar
• Gomperts RJ, Jelinska K, Davies S, Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. BJOG 2008;115:1171–5.
   PubMed Web of Science ®Google Scholar
• Boersma AA, Meyboom-de Jong B. Medical abortion in primary care: Pitfalls and benefits. West Indian Med J 2009;58:604–7.
   PubMedGoogle Scholar
• Wiebe E, Dunn S, Guilbert E, Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol. Obstet Gynecol 2002;99:813–9.
   PubMed Web of Science ®Google Scholar
• Middleton T, Schaff E, Fielding SL, Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception 2005;72:328–32.
   PubMed Web of Science ®Google Scholar
• Fjerstad M, Sivin I, Lichtenberg ES, Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 days. Contraception 2009;80: 282–6.
   PubMed Web of Science ®Google Scholar
• Tran NT, Jang MC, Choe YS, Feasibility, efficacy, safety and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea. Int J Gynaecol Obstet 2010;109:209–12.
   PubMed Web of Science ®Google Scholar
• Gallo MF, Castleman L, Mitchell EM. A systematic review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation. Contraception 2006;74:36–41.
   PubMed Web of Science ®Google Scholar
• Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004;103:738–45.
   PubMed Web of Science ®Google Scholar
• Lohr PA, Wade J, Riley L, Women's opinions on the home management of early medical abortion in the UK. J Fam Plann Reprod Health Care 2010;36:21–5.
   PubMed Web of Science ®Google Scholar
• Kero A, Wulff M, Lalos A. Home abortion implies radical changes for women. Eur J Contracept Reprod Health Care 2009;14:324–33.
   PubMed Web of Science ®Google Scholar
• Faucher P, Baunot N, Madelenat P. Efficacité et acceptabilité de l'interruption de grossesse par méthode médicamenteuse pratiquée sans hospitalisation dans le cadre d'un réseau ville-hôpital: Étude prospective sur 433 cas. [The efficacy and acceptability of home medical abortion provided in a setting linked with the hospital: A prospective study of 433 patients.] Gynecol Obstet Fertil 2005;33:220–7.
   PubMedGoogle Scholar
• Bracken H, Nguyen Thi Nhu, Schaff E, Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion. Obstet Gynecol 2007;109: 895–901.
   PubMed Web of Science ®Google Scholar
• Niniimäki M, Martikainen H, Talvensaari-Mathilla A. Increased risk for medical abortion failure for multiparous women. Int J Gynaecol Obstet 2004;87:174–5.
   PubMed Web of Science ®Google Scholar
• Haimov-Kochman R, Arbel R, Sciaky-Tamir Y, Risk factors for unsuccessful medical abortion with mifepristone and misoprostol. Acta Obstet Gynaecol Scand 2007;86:462–6.
   PubMed Web of Science ®Google Scholar
• Chien LW, Liu WM, Tzeng CR, Au HK. Effect of previous live-birth and prior route of delivery on the outcome of early medical abortion. Obstet Gynecol 2009;113:669–74.
   PubMed Web of Science ®Google Scholar